• Volume 13,Issue 11,2014 Table of Contents
    Select All
    Display Type: |
    • >Brief Introduction of Expert Soliciting Special Topic
    • Brief Introduction of Expert Soliciting Special Topic

      2014, 13(11):0-0.

      Abstract (1499) HTML (0) PDF 97.59 K (1862) Comment (0) Favorites

      Abstract:

    • >Contents
    • Chinese language

      2014, 13(11):1-2.

      Abstract (1567) HTML (0) PDF 221.49 K (1937) Comment (0) Favorites

      Abstract:

    • English language

      2014, 13(11):3-4.

      Abstract (1620) HTML (0) PDF 97.19 K (1915) Comment (0) Favorites

      Abstract:

    • >Editorial
    • Management of multiple metabolism disorders in the elderly diabetic patients

      2014, 13(11):801-804. DOI: 10.3724/SP.J.1264.2014.000185

      Abstract (1831) HTML (0) PDF 330.81 K (1869) Comment (0) Favorites

      Abstract:Geriatric diabetes refers to the population aged 60 or older suffering from diabetes mellitus, including those diagnosed before and after being 60 years old. The elderly with diabetes often have many other coexisting metabolism disorders, and are associated with increased levels of blood glucose, higher morbidity and mortality, and lower awareness rate, diagnosis rate and treatment rate when compared to younger diabetic patients. Therefore, clinicians should made comprehensive and overall assessment on the elderly, and develop an individualized control goal under the policy of “prudent flexibility and appropriate supervisory”. We also should focus on comprehensive management and implement a treatment strategy of safety, efficiency and modesty so as to improve the overall management for the elderly with diabetes.

    • >Clinical Research
    • Risk factors for nonalcoholic fatty liver disease and fatty liver fibrosis in type 2 diabetic inpatients

      2014, 13(11):805-810. DOI: 10.3724/SP.J.1264.2014.000186

      Abstract (1870) HTML (0) PDF 499.55 K (1943) Comment (0) Favorites

      Abstract:Objective To investigate the risk factors for nonalcoholic fatty liver disease (NAFLD) and fatty liver fibrosis in type 2 diabetes mellitus (T2DM) inpatients. Methods A total of 1 109 T2DM patients hospitalized in our department from May 2008 to December 2011 were subjected in the study. Their clinical data, such as medical history, results of laboratory examinations, and hepatic ultrasonograms were collected and analyzed. They were divided into T2DM group and T2DM&NAFLD group according to the ultrasonic tomography results. Then the latter group was further assigned into non-fibrosis subgroup, uncertain subgroup and fibrosis subgroup according to NAFLD fibrosis score (<-1.455, from -1.455 to 0.676, or >0.676). Results (1) Body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), diastolic blood pressure (DBP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), total bilirubin (TBIL), total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C), serum uric acid (UA), fasting blood glucose (FBG), 2-hour postprandial blood glucose (2hPBG), fasting C peptide (FCP), and HOMA-C peptide were significantly higher (P<0.05 or P<0.01), while age, T2DM course, and high density lipoprotein cholestererol (HDL-C) were significantly lower in T2DM&NAFLD group than in T2DM group (P<0.01). (2) Logistic analysis showed that BMI [odds ratio (OR)=1.325, 95% CI=1.249?1.406], ALT (OR=1.025, 95% CI=1.013?1.038), and TG (OR=1.283, 95% CI=1.105?1.490) were the major risk factors for NAFLD in T2DM patients, while HDL-C (OR=0.532, 95% CI=0.286?0.989) was the protective factor. (3) Among the patients with NAFLD, the prevalence of fatty liver fibrosis was 13.4%. The age, diabetic course, BMI, WC, HC, systolic blood pressure (SBP), AST/ALT, GGT and hemoglobin Alc (HbA1c) were significantly higher (P<0.01), but the ALT, albumin (ALB), TG and platelet (Plt) were significantly lower in the fibrosis subgroup than in the non-fibrosis and uncertain subgroups (P<0.01 or P<0.05). (4) Ordinal logistic regression indicated that the age, BMI, ALB, AST/ALT and Plt were the risk factors for fatty liver fibrosis. Conclusion Higher prevalence of coexisting NAFLD is found in the T2DM patients, which is closely associated with BMI, TG, ALT and HDL-C. What’s more, the T2DM patients with coexisting NAFLD are prone to developing liver fibrosis, which is closely associated with the age, BMI, AST/ALT, ALB and Plt.

    • Serum level of cystatin C is associated with cognitive impairment in elderly type 2 diabetic patients

      2014, 13(11):811-815. DOI: 10.3724/SP.J.1264.2014.000187

      Abstract (1630) HTML (0) PDF 406.21 K (1779) Comment (0) Favorites

      Abstract:Objective To investigate the correlation of serum cystatin C (Cys C) level with cognitive impairment in the elderly type 2 diabetic (T2DM) patients. Methods A total of 352 T2DM patients hospitalized in Department of Geriatrics from December 2011 to December 2013 were included in this cross-sectional study. Mini-Mental Status Examination (MMSE) and Montreal Cognitive Assessment (MoCA) were applied to evaluate their cognitive function. According to the results, the cohort was divided into normal cognition group (NC, n=146), mild cognitive impairment group (MCI, n=112), and Alzhermer’s disease group (AD, n=94). Their blood glucose, blood lipids, Cys C levels, and liver and kidney function were tested. The clinical features and Cys C levels were compared among the 3 groups. Results There were significant differences in serum Cys C levels among the 3 groups (all P<0.05). The patients in NC group had the lowest serum level of Cys C, followed by those from MCI and AD groups. Spearman correlation analysis showed that the serum level was positively correlated with age, duration of diabetes, triglycerides, serum creatinine, and HbA1c (r=0.352, 0.199, 0.177, 0.616, and 0.368, respectively, all P<0.05), and was negatively correlated with the scores of MMSE, MoCA and high density lipoprotein-cholesterol (r=-0.186, -0.237, and -0.185, respectively, P<0.05). Logistic regression analysis showed that the serum level of Cys C (P=0.011, OR=2.120), age (P=0.021, OR=3.401), diabetes duration (P=0.033, OR=3.102), and HbA1c (P=0.010, OR=2.691) were independent impact factors for diabetic cognitive impairment in the elderly. Conclusion Serum Cys C is correlated with cognitive impairment in the elderly with T2DM. High serum level of Cys C predicts the increasing risk of cognitive impairment in the population.

    • Effects of single nucleotide polymorphism of transcription factor 2 on efficiency of repaglinide and rosiglitazone: a clinical report of 209 cases

      2014, 13(11):816-821. DOI: 10.3724/SP.J.1264.2014.000188

      Abstract (2105) HTML (0) PDF 407.68 K (2070) Comment (0) Favorites

      Abstract:Objective To investigate the relationship of transcription factor 2 (TCF2) gene polymorphism with the efficiency of repaglinide or rosiglitazone in the patients with newly-diagnosed type 2 diabetes mellitus (T2DM). Methods A total of 209 newly-diagnosed T2DM patients were prospectively recruited in this study. They were randomly assigned into 2 groups, and were treated with repaglinide (n=104) and rosiglitazone (n=105) for 48 consecutive weeks respectively. Anthropometric parameters and indices related to glucose and lipid metabolism were tested before and after the treatment. All patients were genotyped for TCF2 rs4430796 by Sequenom. The efficiency of the 2 drugs were analyzed in the patients with different genotypes. Results Among the 209 patients, 181 of them completed the 48-week follow-up. Their frequencies of AA, GA and GG genotypes were 50.2%, 39.2% and 10.6%, respectively. In the rosiglitazone cohort, there were significant differences in fasting insulin levels and HOMA-β scores at baseline (for assessment of beta-cell functionality) among the 3 genotype groups. After 24- or 48-week treatment, arginine stimulation test showed that significant differences were seen in acute insulin response (AIR) among the 3 genotype groups in the patients treated by rosiglitazone (P<0.05). For the repaglinide cohort, there were significant differences in the fasting insulin levels and HOMA-IR among the 3 genotype groups after 24 weeks’ treatment. Conclusion Variation of rs4430796 in TCF2 is associated with the response to rosiglitazone or repaglinide treatment in the patients with type 2 diabetes.

    • Risk factors for urinary tract infection in type 2 diabetes mellitus inpatients

      2014, 13(11):822-825. DOI: 10.3724/SP.J.1264.2014.000189

      Abstract (2430) HTML (0) PDF 339.74 K (2251) Comment (0) Favorites

      Abstract:目的 分析住院2型糖尿病患者尿路感染的患病情况及其临床特点,并探讨2型糖尿病患者合并尿路感染的危险因素。方法 回顾性地分析香港大学深圳医院2013年10月至2014年9月内分泌与代谢科住院的2型糖尿病患者共249例,收集相应临床资料,比较尿路感染组与非感染组患者年龄、性别、体质量指数、糖尿病病程、糖化血红蛋白(HbA1c)、估算肾小球滤过率(eGFR)、肌酐、尿微量白蛋白/肌酐(ACR)、24h尿微量白蛋白定量、尿糖等指标的异同,分析2型糖尿病患者合并尿路感染的危险因素。结果 住院2型糖尿病患者合并尿路感染的患病率为16.1%;年龄、性别、eGFR、ACR、24h尿微量白蛋白定量、肌酐在两组之间差异具有统计学意义(P<0.05),女性、年龄越大、肾功能越差、尿微量白蛋白越多的患者越易合并尿路感染。而尿糖、糖尿病病程、HbA1c、体质量指数在各组之间差异无统计学意义。logistic回归分析显示性别、肌酐是尿路感染的独立危险因素。结论 2型糖尿病患者合并尿路感染与性别、肌酐相关,女性、肾功能不良的患者是高危人群。

    • Association of glycosylated albumin and glycosylated hemoglobin A1c with glycemic excursions in elderly type 2 diabetic patients

      2014, 13(11):826-830. DOI: 10.3724/SP.J.1264.2014.000190

      Abstract (2081) HTML (0) PDF 607.10 K (2352) Comment (0) Favorites

      Abstract:Objective To analyze the correlation of glycosylated albumin (GA) and glycosylated hemoglobin A1c (HbA1c) with mean amplitude of glycemic excursions (MAGE) and standard difference of blood glucose (SDBG) in elderly type 2 diabetic patients, so as to provide theoretical evidences for complete assessment of GA and HbA1c. Methods A total of 660 elderly type 2 diabetic patients hospitalized in our department from February 2013 to February 2014 were enrolled in this study. Fasting plasma glucose (FPG), HbA1c, GA, fasting C peptide (FCP), 2-hour postprandial blood glucose (2hPBG), and 2-hour C peptide (2hCP) were examined in all the subjects. The 3-day continuous blood glucose monitoring of the enrolled subjects were performed by continuous glucose monitoring system. MAGE and SDBG were used to assess to glycemic excursions. Mean blood glucose (MBG) was used to assess the overall glucose level. Results (1) Among the 660 enrolled subjects, there were 346 men and 314 women with age of (66±6) years, diabetes course of 8.0(4.0?13.8)years, HbA1c of 8.2% (6.7%?9.6%), GA of 21.1% (17.6%?25.9%), MAGE of 5.3(3.9?7.2)mmol/L, SDBG of 2.1(1.6?2.7)mmol/L, and MBG of 8.6(7.3?10.1)mmol/L. (2) Univariate correlation analysis showed that GA was significantly correlated with HbA1c (r=0.836, P<0.01), and also positively correlated with FPG, 2hPBG and MBG (r=0.604, 0.670 and 0.650, respectively, P<0.01). HbA1c also had positive correlation with FPG, 2hPBG and MBG (r=0.603, 0.634 and 0.661, respectively, P<0.01). (3) Univariate correlation analysis indicated that GA had positive correlation with MAGE and SDBG (r=0.485 and 0.529, P<0.01). HbA1c was also positively correlated with MAGE and SDBG (r=0.417 and 0.495, P<0.01). (4) Stepwise multivariate regression analysis demonstrated that GA level was independently correlated with the glycemic excursion indices, MAGE and SDBG. Conclusion Compared with HbA1c, GA can reflect better postprandial glucose level and glycemic excursions.

    • Serum levels of retinol binding protein 4, adiponectin and tumor necrosis factor-alpha and their correlations in patients with obesity and type 2 diabetes mellitus

      2014, 13(11):831-835. DOI: 10.3724/SP.J.1264.2014.000191

      Abstract (2138) HTML (0) PDF 407.15 K (2590) Comment (0) Favorites

      Abstract:Objective To detect the serum levels of retinol binding protein 4 (RBP4), adiponectin and tumor necrosis factor-alpha (TNF-α) in the patients with obesity and type 2 diabetes mellitus (T2DM), and to explore their correlations. Methods A total of 135 Chinese individuals living in Shanghai area were divided into the subjects with normal glucose regulation and normal body mass (NBM-NGR), overweight or obese subjects with normal glucose regulation (OW/OB-NGR), T2DM with normal body mass (NBM-T2DM) and T2DM with overweight or obesity (OW/OB-T2DM). The body fat, biochemical indices and the serum levels of RBP4, adiponectin and TNF-α were determined. Results Serum RBP4 levels were significantly higher in the subjects with T2DM and OW/OB-NGR than in those with NBM-NGR, and also in those with OW/OB-T2DM than in those with NBM-T2DM. Serum adiponectin levels were significantly lower in those with T2DM and OW/OB-NGR than in those of NBM-NGR. Serum TNF-α levels were significantly higher in those with T2DM than in those with NBM-NGR and OW/OB-NGR (P<0.05 or 0.01). Spearman analysis indicated that RBP4 was negatively correlated to adiponectin but positively to TNF-α, and TNF-α had a negative correlation with adiponectin (P<0.05 or 0.01). Multiple stepwise regression analysis showed that triglycerides (TG) and waist-hip ratio (WHR) were the independent risk factors for RBP4. TG, sex, hemoglobin A1c (HbA1c) and high density lipid protein-cholesterol (HDL-C) were the independent risk factors for adiponectin. HbA1c was the independent risk factor for TNF-α. Conclusion RBP4 is closely associated with abdominal obesity, but has no correlation with blood glucose. Adiponectin and TNF-α are mainly related to glucose metabolism. RBP4 is related with adiponectin and TNF-α.

    • Predictive value of serum uric acid for metabolic syndrome in first-degree relatives of type 2 diabetic patients

      2014, 13(11):836-840. DOI: 10.3724/SP.J.1264.2014.000192

      Abstract (2160) HTML (0) PDF 399.31 K (1977) Comment (0) Favorites

      Abstract:Objective To determine whether the serum level of uric acid is associated with the components of metabolic syndrome (MS) criteria and whether uric acid is an independent predictive factor for MS in a high-risk group of type 2 diabetes mellitus (T2DM), first-degree relatives of T2DM patients. Methods A total of 322 first-degree relatives of T2DM patients (119 males and 203 females, aged from 40 to 70 years) were recruited in this study. Their height, body mass, blood pressure, liver and kidney functions, blood lipid profiles and body mass index (BMI) were measured and calculated, and oral glucose tolerance test was carried out. MS was defined according to the Metabolic Syndrome Diagnostic Criteria (2004) by Chinese Diabetes Society. Results In the cohort, the serum level of uric acid was associated with the height, body mass, BMI, 2-hour postprandial blood glucose (2hPBG), systolic blood pressure(SBP), diastolic blood pressure (DBP), triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) level in both sexes (r=0.376, 0.450, 0.285, 0.127, 0.244, 0.225, 0.395, and -0.184, respectively; P<0.05). The prevalence of MS was significantly higher in uric acid 365?537μmol/L (male, 62.1%) and 283?411μmol/L (female, 32.7%) than in uric acid 0?274, and 275?320μmol/L (male, 30.0% and 26.7%) and 0?188, and 189?230μmol/L (female, 7.8% and 9.6%). The serum level of uric acid was significantly higher in the MS people than in those without [(315.83±83.97) vs (251.80±75.21)μmol/L, P<0.01]. Average level of uric acid was increased with the increasing number of the MS criteria components, either in male or in female (P<0.05). Univariate analysis on uric acid for MS indicated that the age-adjusted odds ratios and 95% confidence interval were 1.008 and 1.002 to 1.013 for males (P=0.005) and 1.010 and 1.004?1.016, (P=0.001) for females. But multivariate logistic regression showed that the effect of uric acid was not significant. Conclusion Uric acid is associated with the most components of MS criteria. MS patients have higher uric acid levels, but the level is probably not an independent factor to predict MS.

    • Clinical value of prealbumin in middle-aged and elderly patients with newly-diagnosed diabetes and its influencing factors

      2014, 13(11):841-846. DOI: 10.3724/SP.J.1264.2014.000193

      Abstract (1806) HTML (0) PDF 475.19 K (2427) Comment (0) Favorites

      Abstract:Objective To investigate the clinical value of prealbumin (PA) in middle-aged and elderly newly-diagnosed diabetic patients and its influencing factors. Methods A total of 538 patients (≥45 years old) with newly diagnosed diabetes in our department from January 2010 to December 2012 were recruited in this study. They were divided into 4 groups according to the quartiles of their PA levels, and received routine physical examination and biochemical tests, including body mass index (BMI), blood pressure, fasting blood glucose, hemoglobin (Hgb), liver and kidney functions, lipid profile, fasting C-peptide, glycosylated hemoglobin (HbAlc), glycosylated albumin (GA), C-reactive protein (CRP), etc. Results The PA level in this cohort was significantly higher in the males than in the females [(239±55) vs (227±53)mg/L, P<0.01] and in a trend of decrease with the increase of age (P<0.05). As the PA rose, the BMI, waist circumference, diastolic blood pressure (DBP), Hgb, albumin, γ-glutamyl transpeptidase, total bilirubin, total cholesterol (TC), triglycerides (TG), creatinine, uric acid (UA) and fasting C-peptide were increased (P<0.05), but the age, HbA1c, GA and CRP were decreased (P<0.05). After controlling age, gender and BMI, partial correlation analysis showed that PA was positively correlated with Hgb, albumin, TC, TG, creatinine, UA and fasting C-peptide (all P<0.01), but negatively correlated with HbA1c, GA and CRP (P<0.01). The prevalence of hypo-prealbuminemia (defined as PA <200mg/L) was 27.7% in the cohort. Multivariate logistic regression showed that the GA (OR=1.056, 95%CI=1.021?1.092, P<0.01) and CRP levels (OR=1.273, 95%CI=1.092?1.485, P<0.01) were independent risk factors, while Hgb (OR=0.978, 95% CI=0.961?0.997, P=0.02), albumin (OR=0.738, 95% CI=0.668?0.815, P<0.01), TC (OR=0.747, 95%CI=0.561?0.994; P=0.045) and fasting C-peptide (OR=0.678, 95%CI=0.504?0.911, P=0.01) were protective factors for hypo-prealbuminemia in middle-aged and elderly newly-diagnosed diabetic patients. The cutoff values of PA for the hypo-prealbuminemia deduced by receiver operating characteristic (ROC) curve were 25%, the area under the ROC curve was 0.686 (95% CI=0.638?0.735, P<0.01), and its sensitivity was 76.4% and specificity 53.4%. Conclusion PA level is affected by nutrition status, inflammatory status, blood glucose and serum lipids in middle-aged and elderly newly-diagnosed diabetic patients. The low level of PA in the subjects might be due to their increased blood glucose.

    • >Basic Research
    • Berberine enhances glucose metabolism in absence of AMP-activated protein kinase activation

      2014, 13(11):847-851. DOI: 10.3724/SP.J.1264.2014.000194

      Abstract (2802) HTML (0) PDF 631.04 K (2924) Comment (0) Favorites

      Abstract:Objective To investigate whether berberine exerts hypoglycemic effect in dependence of adenosine 5¢-monophosphate-activated protein kinase (AMPK) signal pathway. Methods After human liver hepatocellular cell line HepG2 and mouse myoblast cell line C2C12 were treated with berberine at different concentrations, glucose consumption and lactate production were used to evaluate the glucose-lowering and anaerobic glycolysis effects of berberine. Compound C (CC), an AMPK inhibitor, and recombinant adenovirus Ad-DN-AMPK expressing dominant negative mutant of AMPK, were used to inhibit the expression and block the activity of AMPK in the cells. AMPK phosphorylation and acetyl coA carboxylase (ACC) phosphorylation were measured with Western blotting to assess the activity of AMPK pathway. Results Berberine significantly increased glucose consumption and lactate production in HepG2 and C2C12 cells in a dose-dependent manner. AMPK and ACC phosphorylation were significantly stimulated by 5 and 10μmol/L berberine. CC and adenovirus-dominant negative-AMPK (Ad-DN-AMPK) adenovirus obviously inhibited AMPK activity, but failed to diminish the promotion of glucose utilization and lactate production induced by berberine. Conclusion Berberine significantly enhances glucose consumption by stimulating glucose metabolism, in absence of AMPK pathway activation. Therefore, even in the case of the expression or activity of AMPK is inhibited, berberine is still able to exert a significant hypoglycemic effect.

    • Expression of Arc/Arg3.1 in diabetic rat hippocampus and its relationship with cognitive function

      2014, 13(11):852-856. DOI: 10.3724/SP.J.1264.2014.000195

      Abstract (1774) HTML (0) PDF 662.54 K (2044) Comment (0) Favorites

      Abstract:Objective To analyze the correlation of cognitive function with the expression of Arc protein and amyloid-beta peptide (Aβ) in the hippocampus of diabetic rats, and to assess the role of synaptic plasticity in the possible pathogenesis of diabetic encephalopathy (DE). Methods Thirty male SPF SD rats (8 weeks old) were randomly assigned to diabetes mellitus (DM) group and control group. After 4 weeks of high fat diet feeding, the rats of DM group were injected intraperitoneally with streptozotocin at a dose of 30mg/kg to establish diabetic model. Body mass, fasting blood glucose (FBG), and fasting serum insulin (FSI) were monitored at several stages, and insulin sensitivity index (ISI) was calculated. At the end of the experiment, water maze test was carried out to evaluate the cognition of all the rats. The expression of Arc and Aβ in the hippocampus was detected and observed by ELISA, immunohistochemistry and Western blotting. Results The DM group spent shorter time in the target quadrant (P<0.01) and lower frequency of crossing the original platform site (P<0.01) than the control group. The expression level of Aβ was obviously higher, while that of Arc/Arg3.1 significantly lower in the DM group than in the control group (P<0.01). Conclusion The cognitive impairment in diabetic rats is possibly related to the decreased Arc expression-induced synaptic plasticity imbalances, and further increased Aβ deposition and neuronal damage.

    • Intermittent injection of osteocalcin prevents high fat diet-induced nonalcoholic fatty liver disease in mice

      2014, 13(11):857-862. DOI: 10.3724/SP.J.1264.2014.000196

      Abstract (1859) HTML (0) PDF 869.00 K (2739) Comment (0) Favorites

      Abstract:Objective To investigate whether exogenous osteocalcin intervention prevents high fat diet-induced nonalcoholic fatty liver disease (NAFLD) in wild type mice. Methods Five-week-old C57Bl/6J male mice were randomly divided into 4 groups, that is, normal diet, high fat diet, and high fat diet+osteocalcin 3 or 10ng/(g·d) groups. The body mass, blood glucose, and food intake were monitored during the 24 weeks’ experiment. Serum levels of total cholesterol (TC), triglycerides (TG), free fatty acid (FFA), and tumor necrosis factor α (TNF-α) and liver contents of TC and TG were measured at the end of the study. Oil Red O and hematoxylin-eosin staining were performed to observe the morphology of the livers. Results Compared with high fat diet group, the groups treated by different doses of osteocalcin had significantly decreased total fat mass (including the fat around epididymides and kidneys as well as subcutaneous fat) and total fat mass/body mass ratio (P<0.001), better fasting blood glucose and glucose tolerance (P<0.05?0.001), and obviously reduced serum levels of TC, TG, FFA and TNF-α (P<0.05). Osteocalcin treatment prevented high fat diet-induced liver steatosis and resulted in remarkably decreased liver mass, ratio of liver mass to body mass as well as liver TC and TG levels (P<0.05). Conclusion Intermittent injection of osteocalcin significantly prevents high fat diet-induced NAFLD, improves glucose-lipids metabolism and reduces serum TNF-α level.

    • >Review
    • Pay attention to malnutrition in elderly diabetic patients

      2014, 13(11):863-866. DOI: 10.3724/SP.J.1264.2014.000197

      Abstract (2051) HTML (0) PDF 323.61 K (2379) Comment (0) Favorites

      Abstract:A higher proportion of malnutrition is found in the elderly with diabetes, especially in those hospitalized ones, but this phenomenon is easier to be ignored. For the elderly patients with diabetes mellitus, their special physiological status, social factors, comorbidities and taking oral hypoglycemic drugs, all increase the risk for malnutrition. Consequently, it can make patients extend the length of hospital stays, increase the risk for life-threatening complications, and then arise the mortality. So, clinicians should enhance the screening of nutritional status and emphasize the nutritional support in aged diabetes patients. What’s more, they also need to reduce the use of some oral hypoglycemic drugs, advocate the application of insulin therapy and set individualized treatment plan, so as to improve the quality of life in elderly diabetic population.

    • Clinical application of 1,5-anhydroglucitol and the research progress

      2014, 13(11):867-871. DOI: 10.3724/SP.J.1264.2014.000198

      Abstract (1725) HTML (0) PDF 407.88 K (2990) Comment (0) Favorites

      Abstract:1,5-Anhydroglucitol (1,5-AG) is a metabolically inert polyol that competes with glucose for reabsorption in the kidneys. The stable level of 1,5-AG is rapidly depleted as blood glucose levels exceed the renal threshold for glucosuria. Thus, 1,5-AG can be used as a validated marker of short-term glycemic control. This article reviewed the features and research progress of 1,5-AG and assessed its advantages as well as limitations as a glycemic marker in clinical practice.

    • Epidemic characteristics of overweight, obesity and abdominal obesity in Chinese adult population

      2014, 13(11):872-875. DOI: 10.3724/SP.J.1264.2014.000199

      Abstract (1931) HTML (0) PDF 308.08 K (2333) Comment (0) Favorites

      Abstract:Obesity is in a rapid growth trend in the world and our country. It refers to the excessive accumulation of body fat and significantly increases the risk of cardiovascular metabolic disorders. Some evidence has shown that, in some populations, the change in prevalence of overweight/obesity and abdominal obesity is inconsistent. In this paper, we summarized on the secular transition of the prevalence of overweight/obesity and abdominal obesity in Chinese adults.

    • Glycosylated proteins in diabetes and at high altitude

      2014, 13(11):876-880. DOI: 10.3724/SP.J.1264.2014.000200

      Abstract (1805) HTML (0) PDF 382.85 K (2751) Comment (0) Favorites

      Abstract:Evidence shows that various proteins in diabetic patients are glycosylated in a slow, stable, and irreversible biochemical reaction, and then form some determinable glycosylation end products, such as glycosylated hemoglobin A (HbA1c) and glycosylated albumin (GA). Serum levels of HbA1c and GA are closely associated with blood glucose and diabetes complications, and their test results are affected by some factors, such as hemoglobin (Hb) and albumin. Hypoxia, cold and other unique geographical and climatic conditions at the high altitude make the multi-organic and multi-systematic pathological and physiological status of human body different from those living at the plains, and these differences make the diagnosis and treatment of diabetes patients who live at the high altitude more complicated and distinctive than people at the plain area. This review mainly introduced HbA1c, GA and some related investigations at the high altitude.

Superintendor:Chinese PLA General Hospital

Sponsor:Medical Innovation Research Division, Chinese PLA General Hospital/ National Clinical Research Center for Geriatric Diseases (Chinese PLA General Hospital)/Department of Cardiology, Sixth Medical Center, Chinese PLA General Hospital

Editor-in-Chief:Fan Li

Executive Editor:Chen Yundai

Tel:010-66936756

E-mail: zhlndqg@mode301.cn

ISSN:1671-5403

CN:11-4786/R

Founding Date:2002

Publishing Cycle:Monthly

Postal Code:82-408

  • Most Read
  • Most Cited
  • Most Downloaded
Press search
Search term
From To